Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains

Infection and Immunity

Volumn 75, Issue 10, 2007, Pages 5035-5042

  Olivier, Verena ^a   Haines III, G Kenneth ^a,b   Tan, Yanping ^a,c   Fullner Satchell, Karla J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CHOLERA TOXIN; HEMAGGLUTININ; PROTEINASE; STREPTOMYCIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOTYPE; CHOLERA; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOLYSIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INTESTINE EPITHELIUM; INTESTINE INFECTION; LETHALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; VIBRIO CHOLERAE; WILD TYPE;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIAL VACCINES; CHOLERA; CHOLERA TOXIN; COLONY COUNT, MICROBIAL; FEMALE; HEMOLYSIN PROTEINS; INTESTINE, SMALL; LIVER; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; SPLEEN; SURVIVAL ANALYSIS; VIBRIO CHOLERAE O1; VIRULENCE FACTORS;

EID: 34848912537     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00506-07     Document Type: Article

References (46)

1. Alm, R. A., G. Mayrhofer, I. Kotlarski, and P. A. Manning. 1991. Amino-terminal domain of the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic. Vaccine 9:588-594.
2. Anderson, A. M., J. B. Varkey, C. A. Petti, R. A. Liddle, R. Frothingham, and C. W. Woods. 2004. Non-O1 Vibrio cholerae septicemia: case report, discussion of literature, and relevance to bioterrorism. Diagn. Microbiol. Infect. Dis. 49:295-297.
3. Benitez, J. A., L. Garcia, A. Silva, H. Garcia, R. Fando, B. Cedre, A. Perez, J. Campos, B. L. Rodriguez, J. L. Perez, T. Valmaseda, O. Perez, M. Ramirez, T. Ledon, M. D. Jidy, M. Lastre, L. Bravo, and G. Sierra. 1999. Preliminary assessment of the safety and immunogenicity of a new CTXφ-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect. Immun. 67:539-545.
4. Blake, P. A., R. E. Weaver, and D. G. Hollis. 1980. Diseases of humans (other than cholera) caused by vibrios. Annu. Rev. Microbiol. 34:341-367.
5. Boardman, B. K., B. M. Meehan, and K. J. F. Satchell. 2007. Growth phase regulation of Vibrio cholerae RTX toxin export. J. Bacteriol. 189:1827-1835.
6. Butterton, J. R., D. T. Beattie, C. L. Gardel, P. A. Carroll, T. Hyman, K. P. Killeen, J. J. Mekalanos, and S. B. Calderwood. 1995. Heterologous antigen expression in Vibrio cholerae vector strains. Infect. Immun. 63:2689-2696.
7. Butterton, J. R., E. T. Ryan, R. A. Shahin, and S. B. Calderwood. 1996. Development of a germfree mouse model of Vibrio cholerae infection. Infect. Immun. 64:4373-4377.
8. Cebra, J. J. 1999 Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69:1046S-1051S.
9. Coelho, A., J. R. Andrade, A. C. Vicente, and V. J. Dirita. 2000. Cytotoxic cell vacuolating activity from Vibrio cholerae hemolysin. Infect. Immun. 68:1700-1705.
10. Cray, W. C., Jr., E. Tokunaga, and N. F. Pierce. 1983. Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. Infect. Immun. 41:735-741.
11. Cvjetanovic, B., and D. Barua. 1972. The seventh pandemic of cholera. Nature 239:137-138.
12. Donnenberg, M. S., and J. B. Kaper. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun. 59:4310-4317.
13. Faruque, S. M., N. Chowdhury, M. Kamruzzaman, M. Dziejman, M. H. Rahman, D. A. Sack, G. B. Nair, and J. J. Mekalanos. 2004. Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera-endemic area. Proc. Natl. Acad. Sci. USA 101:2123-2128.
14. Figueroa-Arredondo, P., J. E. Heuser, N. S. Akopyants, J. H. Morisaki, S. Giono-Cerezo, F. Enriquez-Rincon, and D. E. Berg. 2001. Cell vacuolation caused by Vibrio cholerae hemolysin. Infect. Immun. 69:1613-1624.
15. Finkelstein, R. A., M. Boesman-Finkelstein, and P. Holt. 1983. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F. M. Burnet revisited. Proc. Natl. Acad. Sci. USA 80:1092-1095.
16. Fullner, K. J. 2003. Toxins of Vibrio cholerae: consensus and controversy, p. 481-502. In G. Hecht (ed.), Microbial pathogenesis and the intestinal epithelial cell, vol. 26. ASM Press, Washington, DC.
17. Fullner, K. J., J. C. Boucher, M. A. Hanes, G. K. Haines III, B. M. Meehan, C. Walchle, P. J. Sansonetti, and J. J. Mekalanos. 2002. The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J. Exp. Med. 195:1455-1462.
18. Fullner, K. J., and J. J. Mekalanos. 1999. Genetic characterization of a new type IV-A pilus gene cluster found in both classical and El Tor biotypes of Vibrio cholerae. Infect. Immun. 67:1393-1404.
19. Garcia, L., M. D. Jidy, H. Garcia, B. L. Rodriguez, R. Fernandez, G. Ano, B. Cedre, T. Valmaseda, E. Suzarte, M. Ramirez, Y. Pino, J. Campos, J. Menendez, R. Valera, D. Gonzalez, I. Gonzalez, O. Perez, T. Serrano, M. Lastre, F. Miralles, J. Del Campo, J. L. Maestre, J. L. Perez, A. Talavera, A. Perez, K. Marrero, T. Ledon, and R. Fando. 2005. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. Infect. Immun. 73:3018-3024.
20. Goldberg, I., and J. J. Mekalanos. 1986. Cloning of the Vibrio cholerae recA gene and construction of a Vibrio cholerae recA mutant. J. Bacteriol. 165:715-722.
21. Guentzel, M. N., and L. J. Berry. 1974. Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens. Infect. Immun. 10:167-172.
22. Haines, G. K., III, B. A. Sayed, M. S. Rohrer, V. Olivier, and K. J. Satchell. 2005. Role of Toll-like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El Tor strains deficient in production of cholera toxin and accessory toxins. Infect. Immun. 73:6157-6164.
23. Honda, T., and R. A. Finkelstein. 1979. Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios. Infect. Immun. 26:1020-1027.
24. Ichinose, Y., K. Yamamoto, N. Nakasone, M. J. Tanabe, T. Takeda, T. Miwatani, and M. Iwanaga. 1987. Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae. Infect. Immun. 55:1090-1093.
25. Ikigai, H., A. Akatsuka, H. Tsujiyama, T. Nakae, and T. Shimamura. 1996. Mechanism of membrane damage by El Tor hemolysin of Vibrio cholerae O1. Infect. Immun. 64:2968-2973.
26. Kabir, S. 2005. Cholera vaccines: the current status and problems. Rev. Med. Microbiol. 16:101-116.
27. Kaper, J. B., J. G. Morris, Jr., and M. M. Levine. 1995. Cholera. Clin. Microbiol. Rev. 8:48-86.
28. Kenner, J. R., T. S. Coster, D. N. Taylor, A. F. Trofa, M. Barrera-Oro, T. Hyman, J. M. Adams, D. T. Beattie, K. P. Killeen, D. R. Spriggs, et al. 1995. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J. Infect. Dis. 172:1126-1129.
29. Lee, S. H., D. L. Hava, M. K. Waldor, and A. Camilli. 1999. Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99:625-634.
30. Levine, M. M., J. B. Kaper, D. Herrington, G. Losonsky, J. G. Morris, M. L. Clements, R. E. Black, B. Tall, and R. Hall. 1988. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect. Immun. 56:161-167.
31. Lin, W., K. J. Fullner, R. Clayton, J. A. Sexton, M. B. Rogers, K. E. Calia, S. B. Calderwood, C. Fraser, and J. J. Mekalanos. 1999. Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc. Natl. Acad. Sci. USA 96:1071-1076.
32. Mekalanos, J. J., D. J. Swartz, G. D. Pearson, N. Harford, F. Groyne, and M. de Wilde. 1983. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature 306:551-557.
33. Mel, S. F., K. J. Fullner, S. Wimer-Mackin, W. I. Lencer, and J. J. Mekalanos. 2000. Association of protease activity in Vibrio cholerae vaccine strains with decreases in transcellular epithelial resistance of polarized T84 intestinal epithelial cells. Infect. Immun. 68:6487-6492.
34. Mitra, R., P. Figueroa, A. K. Mukhopadhyay, T. Shimada, Y. Takeda, D. E. Berg, and G. B. Nair. 2000. Cell vacuolation, a manifestation of the El Tor hemolysin of Vibrio cholerae. Infect. Immun. 68:1928-1933.
35. Ninin, E., N. Caroff, D. El Kouri, E. Espaze, H. Richet, M. L. Quilici, and J. M. Fournier. 2000. Nontoxigenic Vibrio cholerae O1 bacteremia: case report and review. Eur. J. Clin. Microbiol. Infect. Dis. 19:489-491.
36. Olivier, V., N. H. Salzman, and K. J. F. Satchell. 2007. Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins. Infect. Immun. 75:5043-5051.
37. Rockhill, R. C., M. Lesmana, and A. Moechtar. 1983. Improved method, using staphylococcal beta-hemolysin, for detection of hemolysin(s) produced by Vibrio cholerae biotype El Tor. Southeast Asian J. Trop. Med. Public Health 14:181-185.
38. Satchell, K. J. 2003. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins. Microbes Infect. 5:1241-1247.
39. Sheahan, K. L., C. L. Cordero, and K. J. Satchell. 2004. Identification of a domain within the multifunctional Vibrio cholerae RTX toxin that covalently cross-links actin. Proc. Natl. Acad. Sci. USA 101:9798-9803.
40. Silva, T. M., M. A. Schleupner, C. O. Tacket, T. S. Steiner, J. B. Kaper, R. Edelman, and R. Guerrant. 1996. New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and O139 Vibrio cholerae. Infect. Immun. 64:2362-2364.
41. Tacket, C. O., K. L. Kotloff, G. Losonsky, J. P. Nataro, J. Michalski, J. B. Kaper, R. Edelman, and M. M. Levine. 1997. Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD111. Am. J. Trop. Med. Hyg. 56:533-537.
42. Tacket, C. O., G. Losonsky, J. P. Nataro, L. Comstock, J. Michalski, R. Edelman, J. B. Kaper, and M. M. Levine. 1995. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172:883-886.
43. Tacket, C. O., G. Losonsky, J. P. Nataro, S. J. Cryz, R. Edelman, A. Fasano, J. Michalski, J. B. Kaper, and M. M. Levine. 1993. Safety and immunogenicity of live oral cholera vaccine candidate CVD110, a ΔctxA Δzot Δace derivative of El Tor Ogawa Vibrio cholerae. J. Infect. Dis. 168:1536-1540.
44. Taylor, D. N., K. P. Killeen, D. C. Hack, J. R. Kenner, T. S. Coster, D. T. Beattie, J. Ezzell, T. Hyman, A. Trofa, M. H. Sjogren, et al. 1994. Development of a live, oral, attenuated vaccine against El Tor cholera. J. Infect. Dis. 170:1518-1523.
45. Williams, S. G., S. R. Attridge, and P. A. Manning. 1993. The transcriptional activator HlyU of Vibrio cholerae: nucleotide sequence and role in virulence gene expression. Mol. Microbiol. 9:751-760.
46. Wu, Z., P. Nybom, and K. E. Magnusson. 2000. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell. Microbiol. 2:11-17.